Eagle Bay Advisors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-531
Closed -$48.3K 271
2024
Q4
$48.3K Sell
531
-131
-20% -$12.5K 0.03% 335
2024
Q3
$68.8K Sell
662
-5
-0.7% -$510 0.03% 377
2024
Q2
$64.8K Sell
667
-400
-37% -$36.9K 0.04% 299
2024
Q1
$96.1K Sell
1,067
-176
-14% -$14.9K 0.06% 219
2023
Q4
$99.1K Sell
1,243
-467
-27% -$35.1K 0.06% 212
2023
Q3
$122K Buy
1,710
+475
+38% +$35.5K 0.06% 209
2023
Q2
$95.2K Sell
1,235
-92
-7% -$7.12K 0.05% 228
2023
Q1
$99.8K Sell
1,327
-254
-16% -$18.9K 0.05% 240
2022
Q4
$125K Buy
1,581
+415
+36% +$31.1K 0.07% 190
2022
Q3
$82K Buy
1,166
+36
+3% +$2.82K 0.05% 241
2022
Q2
$90.6K Buy
1,130
+426
+61% +$33.3K 0.05% 225
2022
Q1
$53K Sell
704
-131
-16% -$10.4K 0.04% 130
2021
Q4
$71K Sell
835
-248
-23% -$19.4K 0.05% 266
2021
Q3
$82K Buy
1,083
+719
+198% +$57.1K 0.05% 291
2021
Q2
$32K Buy
+364
New +$29.8K 0.03% 443

Other funds holding CL

Eagle Bay Advisors's CL Position: Q1 2025 in Review

Eagle Bay Advisors sold out of Colgate-Palmolive (CL) in Q1 2025, closing a stake of 531 shares — an estimated $48.3K sold.

Eagle Bay Advisors first reported a position in CL in Q2 2021 and held it in 15 quarters. The position peaked at $125K in Q4 2022. 1,942 funds tracked by Wall St. Rank hold CL as of Q1 2025.

  • Eagle Bay Advisors reported no remaining Colgate-Palmolive position as of Q1 2025 after selling out during the quarter.
  • Eagle Bay Advisors sold 531 Colgate-Palmolive shares in Q1 2025, an estimated $48.3K.
  • Eagle Bay Advisors first reported a position in Colgate-Palmolive in Q2 2021 and held it in 15 quarters.
  • Eagle Bay Advisors's Colgate-Palmolive position peaked at $125K in Q4 2022.
  • 1,942 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2025.

Based on Eagle Bay Advisors's 13F filing for Q1 2025, filed 5 May 2025.